T1	Condition 3 22	Atrial fibrillation
T2	Procedure 46 73	cardiac pacemaker treatment
T3	Device 46 63	cardiac pacemaker
R1	AND Arg1:T2 Arg2:T3	
T4	Procedure 97 118	metal graft treatment
T5	Device 97 108	metal graft
R2	AND Arg1:T4 Arg2:T5	
T6	Condition 124 138	Claustrophobia
T7	Condition 144 171	Acute myocardial infarction
T8	Condition 173 189	cardiac ischemia
T9	Procedure 203 221	6-minute walk test
T10	Condition 223 250	hypertrophic cardiomyopathy
T11	Condition 252 277	constrictive pericarditis
T12	Condition 291 304	valve disease
T13	Qualifier 279 290	significant
R3	Has_qualifier Arg1:T12 Arg2:T13	
T14	Condition 308 332	congenital heart disease
T15	Condition 334 363	severe pulmonary hypertension
T16	Qualifier 334 340	severe
R4	Has_qualifier Arg1:T15 Arg2:T16	
T17	Qualifier 308 318	congenital
R5	Has_qualifier Arg1:T14 Arg2:T17	
*	OR T9 T10 T11 T12 T14 T15
*	OR T8 T7
T18	Scope 203 363	6-minute walk test, hypertrophic cardiomyopathy, constrictive pericarditis, significant valve disease or congenital heart disease, severe pulmonary hypertension
T19	Scope 144 189	Acute myocardial infarction, cardiac ischemia
R6	Subsumes Arg1:T19 Arg2:T18	
T20	Condition 369 391	Ischemic heart failure
T21	Procedure 404 421	revascularization
T22	Negation 392 399	without
R7	Has_negation Arg1:T21 Arg2:T22	
T23	Procedure 439 456	revascularization
T24	Temporal 457 477	within last 6 months
R8	Has_temporal Arg1:T23 Arg2:T24	
*	OR T21 T23
T25	Scope 392 477	without the revascularization or undergone the revascularization within last 6 months
R9	Subsumes Arg1:T20 Arg2:T25	
T26	Procedure 501 516	cardiac surgery
T27	Condition 520 542	cerebrovascular events
T28	Temporal 543 573	within the previous six months
*	OR T27 T26
T29	Scope 501 542	cardiac surgery or cerebrovascular events
R10	Has_temporal Arg1:T29 Arg2:T28	
T30	Procedure 605 628	cardiac transplantation
T31	Observation 592 596	plan
R11	Has_mood Arg1:T30 Arg2:T31	
T32	Condition 653 672	renal insufficiency
T33	Condition 641 648;659 672	hepatic insufficiency
T34	Measurement 674 690	serum creatinine
T35	Value 690 701	>2.0 mg /dl
R12	Has_value Arg1:T34 Arg2:T35	
T36	Measurement 703 706	AST
T37	Measurement 710 713	ALT
T38	Value 717 771	five times higher than the upper limit of normal range
*	OR T36 T37
T39	Scope 703 713	AST or ALT
R13	Has_value Arg1:T39 Arg2:T38	
*	OR T34 T39
*	OR T33 T32
T40	Scope 641 672	hepatic and renal insufficiency
T41	Procedure 793 815	mechanical ventilation
T42	Measurement 831 845	blood pressure
T43	Value 846 854	< 90mmHg
T44	Value 859 868	> 160mmHg
*	OR T44 T43
T45	Scope 846 868	< 90mmHg, or > 160mmHg
T46	Condition 875 896	Chronic heart failure
T47	Condition 914 943	acute hemodynamic disturbance
T48	Condition 947 967	acute decompensation
T49	Temporal 968 987	within last 1 month
*	OR T48 T47
T50	Scope 914 967	acute hemodynamic disturbance or acute decompensation
R14	Has_scope Arg1:T46 Arg2:T50	
R15	Has_temporal Arg1:T46 Arg2:T49	
T51	Measurement 994 1000	Mobitz
T52	Value 1001 1015	Type II or III
T53	Condition 1017 1041	atrial ventricular block
R16	Has_value Arg1:T51 Arg2:T52	
R17	AND Arg1:T53 Arg2:T51	
T54	Qualifier 1042 1048	severe
T55	Condition 1049 1071	ventricular arrhythmia
R18	Has_qualifier Arg1:T55 Arg2:T54	
T56	Observation 1098 1125	premature ventricular beats
T57	Condition 1150 1173	ventricular tachycardia
T58	Qualifier 1136 1149	non-sustained
T59	Multiplier 1127 1135	frequent
T60	Measurement 1181 1196	Serum potassium
T61	Value 1196 1206	<3.2mmol/L
T62	Value 1210 1220	>5.5mmol/L
*	OR T61 T62
T63	Scope 1196 1220	<3.2mmol/L, or>5.5mmol/L
R19	Has_scope Arg1:T60 Arg2:T63	
R21	Has_qualifier Arg1:T57 Arg2:T58	
R20	Has_multiplier Arg1:T57 Arg2:T59	
T64	Multiplier 1089 1097	frequent
T65	Qualifier 1073 1084	polymorphic
R22	Has_multiplier Arg1:T56 Arg2:T64	
R23	Has_qualifier Arg1:T56 Arg2:T65	
T66	Scope 1073 1173	polymorphic and frequent premature ventricular beats, frequent non-sustained ventricular tachycardia
R24	Subsumes Arg1:T55 Arg2:T66	
*	OR T55 T53
T67	Person 1227 1233	Female
T68	Condition 1245 1253	pregnant
T69	Observation 1257 1261	plan
T70	Condition 1272 1280	pregnant
R25	Has_mood Arg1:T70 Arg2:T69	
*	OR T68 T70
T71	Person 1304 1310	female
T72	Observation 1326 1335	unmarried
T73	Observation 1348 1358	bear child
T74	Negation 1344 1347	not
R26	Has_negation Arg1:T73 Arg2:T74	
T75	Value 1394 1412	less than 6 months
T76	Observation 1378 1393	life expectancy
R27	Has_value Arg1:T76 Arg2:T75	
T77	Context_Error 1448 1530	Subject participated in any other clinical trial within the previous three months;
T78	Condition 1569 1574	tumor
T79	Observation 1549 1565	previous history
R28	Has_temporal Arg1:T78 Arg2:T79	
T80	Condition 1587 1592	tumor
T81	Temporal 1579 1586	current
R29	Has_temporal Arg1:T80 Arg2:T81	
T82	Condition 1618 1639	pre-cancerous disease
T83	Procedure 1654 1678	pathological examination
T84	Condition 1688 1712	ductal carcinoma in situ
T85	Condition 1716 1745	cervical epithelial dysplasia
*	OR T85 T84
R30	AND Arg1:T82 Arg2:T83	
T86	Scope 1688 1745	ductal carcinoma in situ or cervical epithelial dysplasia
R31	Subsumes Arg1:T82 Arg2:T86	
*	OR T80 T82 T78
T87	Procedure 1766 1786	physical examination
T88	Procedure 1788 1805	X-ray examination
T89	Procedure 1807 1834	type-B ultrasonic detection
T90	Procedure 1838 1851	other methods
*	OR T90 T89 T88 T87
T91	Scope 1766 1851	physical examination, X-ray examination, type-B ultrasonic detection or other methods
T92	Procedure 1752 1764	Examinations
T93	Undefined_semantics 1752 1764	Examinations
R32	Subsumes Arg1:T92 Arg2:T91	
T94	Condition 1881 1895	malignant mass
T95	Condition 1897 1914	gland hyperplasia
T96	Condition 1918 1925	adenoma
T97	Condition 1931 1949	endocrine activity
T98	Qualifier 1926 1949	with endocrine activity
R33	AND Arg1:T98 Arg2:T97	
R34	Has_qualifier Arg1:T96 Arg2:T98	
*	OR T96 T95 T94 T97 T103
T99	Condition 2002 2018	pheochromocytoma
T100	Condition 2020 2039	thyroid enlargement
*	OR T99 T100
T101	Condition 1954 1963;1974 1992	impact on endocrine function
T102	Condition 1954 1969	impact on heart
*	OR T101 T102
T103	Scope 1954 1992	impact on heart, or endocrine function
T104	Scope 2002 2039	pheochromocytoma, thyroid enlargement
R35	Subsumes Arg1:T103 Arg2:T104	
T105	Scope 1881 2040	malignant mass, gland hyperplasia or adenoma with endocrine activity, or impact on heart, or endocrine function (such as pheochromocytoma, thyroid enlargement)
R36	Has_scope Arg1:T92 Arg2:T105	
T106	Post-eligibility 2047 2224	The Investigator deemed for whatever reason that the subject is not likely to complete the study or comply with the study procedures (due to administration or any other reason).
